These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 18509104)

  • 21. Anti-Chol-1 antigen, GQ1bα, antibodies are associated with Alzheimer's disease.
    Ariga T; Kubota M; Nakane M; Oguro K; Yu RK; Ando S
    PLoS One; 2013; 8(5):e63326. PubMed ID: 23717411
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Multifocal motor neuropathy without conduction blocks and antibodies to GM1 gangliosides].
    Sanadze AG; Kasatkina LF; Gil'vanova OV; Ivanov SA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(8 Pt 1):69-74. PubMed ID: 21946146
    [No Abstract]   [Full Text] [Related]  

  • 23. Seroconversion of anti-GM1 antibodies in patients with amyotrophic lateral sclerosis.
    Haggiag S; Steiner-Birmanns B; Wirguin I; Sicsic C; Brenner T; Steiner I
    Neurology; 2004 Aug; 63(4):755-6. PubMed ID: 15326266
    [No Abstract]   [Full Text] [Related]  

  • 24. Serum anti-GM1 and anti-GD1a antibodies in patients with motor neuron disease.
    Voumvourakis C; Rombos A; Konstantoulakis MM; Segditsa I; Papageorgiou C
    Acta Neurol Scand; 1992 Dec; 86(6):599-602. PubMed ID: 1481647
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IgM anti-GM1 antibodies in the Guillain-Barré syndrome: a serological predictor of the clinical course.
    Bech E; Orntoft TF; Andersen LP; Skinhøj P; Jakobsen J
    J Neuroimmunol; 1997 Jan; 72(1):59-66. PubMed ID: 9003245
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum IgM anti-GM1 ganglioside antibodies in lower motor neuron syndromes.
    Niebroj-Dobosz I; Janik P; Kwieciński H
    Eur J Neurol; 2004 Jan; 11(1):13-6. PubMed ID: 14692882
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The probable auto-antigenic role of lipids (anti-ganglioside antibodies) in the pathogenesis of Alzheimer's disease.
    Koutsouraki E; Hatzifilippou E; Michmizos D; Banaki T; Costa V; Baloyannis S
    J Alzheimers Dis; 2014; 42 Suppl 3():S163-6. PubMed ID: 24898654
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-GM1 antibodies: the cause of otherwise unexplained ophthalmoplegias?
    Kowal L; Gajus MA; Kornberg AJ
    Clin Exp Ophthalmol; 2004 Aug; 32(4):411-4. PubMed ID: 15281977
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inflammatory polyneuropathy after heart transplantation. Its association with antibodies to asialo-GM1 and sulfatide.
    Adair J; Rose J; Alderson K
    Transplantation; 1993 Dec; 56(6):1597-9. PubMed ID: 8305086
    [No Abstract]   [Full Text] [Related]  

  • 30. Results of testing for anti-GM1 antibodies.
    McCombe PA; Wilson R; Prentice RL
    J Clin Neurosci; 2000 May; 7(3):209-12. PubMed ID: 10833617
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Demented versus non-demented very old inpatients: the same comorbidities but poorer functional and nutritional status.
    Zekry D; Herrmann FR; Grandjean R; Meynet MP; Michel JP; Gold G; Krause KH
    Age Ageing; 2008 Jan; 37(1):83-9. PubMed ID: 17971391
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multifocal motor neuropathy. Serum IgM anti-GM1 ganglioside antibodies in most patients detected using covalent linkage of GM1 to ELISA plates.
    Pestronk A; Choksi R
    Neurology; 1997 Nov; 49(5):1289-92. PubMed ID: 9371910
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A case of anti-GM1 antibody positive HTLV-I associated myelopathy (HAM) with polyneuropathy].
    Yanagihara C; Ihara M; Nishimura Y; Oka N
    Rinsho Shinkeigaku; 1999 Sep; 39(9):971-5. PubMed ID: 10614165
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The clinical correlates of high-titer IgG anti-GM1 antibodies.
    Ala TA; Frey WH
    Ann Neurol; 1994 Sep; 36(3):455. PubMed ID: 8080261
    [No Abstract]   [Full Text] [Related]  

  • 35. The presence of Mycoplasma pneumoniae infection and GM1 ganglioside antibodies in Guillain-Barré syndrome.
    Sharma MB; Chaudhry R; Tabassum I; Ahmed NH; Sahu JK; Dhawan B; Kalra V
    J Infect Dev Ctries; 2011 Jul; 5(6):459-64. PubMed ID: 21727645
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibodies to gangliosides in Guillain-Barré syndrome: specificity and relationship to clinical features.
    Gregson NA; Koblar S; Hughes RA
    Q J Med; 1993 Feb; 86(2):111-7. PubMed ID: 8464986
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-fucosyl-GM1 ganglioside IgG and IgM autoantibodies in human serum: no link to pathology.
    Adler G; Pacuszka T; Strugalska M; Targońska I; Panasiewicz M; Lewartowska A
    Immunol Lett; 1996 Sep; 52(2-3):89-93. PubMed ID: 8905401
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-GM1 ganglioside antibodies with differing fine specificities in patients with multifocal motor neuropathy.
    Baba H; Daune GC; Ilyas AA; Pestronk A; Cornblath DR; Chaudhry V; Griffin JW; Quarles RH
    J Neuroimmunol; 1989 Dec; 25(2-3):143-50. PubMed ID: 2584393
    [TBL] [Abstract][Full Text] [Related]  

  • 39. GM1 antibodies in post-polio syndrome and previous paralytic polio.
    Farbu E; Rekand T; Tysnes OB; Aarli JA; Gilhus NE; Vedeler CA
    J Neuroimmunol; 2003 Jun; 139(1-2):141-4. PubMed ID: 12799031
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibodies to GM1 and GD1b in patients with motor neuron disease without plasma cell dyscrasia.
    Shy ME; Evans VA; Lublin FD; Knobler RL; Heiman-Patterson T; Tahmoush AJ; Parry G; Schick P; DeRyk TG
    Ann Neurol; 1989 May; 25(5):511-3. PubMed ID: 2505666
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.